Share on

Global Cell Culture Market Size, Share, Growth, COVID-19 Impact & Trends Analysis Report - Segmented By Product, Application, End User and Region - Industry Forecast (2022 to 2027).

Published: January, 2022
ID: 2593
Pages: 186
Formats: report pdf report excel report power bi report ppt

Global Cell Culture Market Size (2022 to 2027)

The global cell culture market size is estimated to grow USD 30.9 billion by 2027 from USD 18.69 billion in 2022. This market is forecasted to grow at a CAGR of 10.60% during the forecast period. The biotechnology sector has gained importance in the past years due to R&D in healthcare and biological application. The market is experiencing growth due to the demand for monoclonal antibodies, the growing awareness about cell culture-based vaccines, and the importance of single-cell technology for research.

Cell culture is when a cell is removed from an animal or plant tissue and placed in a fluid medium. Under proper conditions, the cell can live and grow. Using this technique, cell lines are established, which are then used for different research purposes such as for chronic diseases and to test new vaccines and medications.

COVID-19 impact on the cell culture market:

Increasing adoption of cell culture techniques for the development of vaccines and biopharmaceuticals is a significant factor driving the growth of the cell culture market. In addition, due to the COVID-19 pandemic, there is a rise in the demand for cell culture product, as the vaccine for COVID -19 are in the trial phase there is the requirement of cell line and different cell culture techniques are used there will be substantial growth in the market from 2020 to 2024.

MARKET DRIVERS:

Expanding the number of regulatory approvals for the increasing demand for improving decisions for single-use technologies, monoclonal antibodies, cell culture-based vaccines, funding for cell-based analysis, and the boat of forwarding cell culture outcomes are primary growth drivers to the global cell culture market. This bottom of the exceptional and forward system is required to improve the global cell culture market in the long run, especially for production on a large-scale basis. The advantages of this are that it is most productive as well as retains a shallow contamination hazard. That serves as a great deal to the players of the market. Besides, with the growing trend encompassing the practice of animal-derived and component-free factors and this recognition of specialization and chemically defined mediums, the global cell culture market is yet to observe extraordinary growth in the following years.

Furthermore, shifting trends towards personalized medicines are major factors anticipated to present growth opportunities for the market. In addition, a rise in the demand for cell culture-based vaccines across the world, which plays an immense role in the healthcare domain, is leveling up the growth of the Cell Culture Market. Furthermore, increasing the scale of research institutes to develop quality drugs in concern towards people's safety is likely to bolster the demand of the cell culture market. Besides, increasing the number of patients suffering from chronic diseases is also accelerating the market's growth extensively. Furthermore, the rise in support from the government by changing schemes to evaluate treatment procedures for ordinary people creates chances for the cell culture market to grow.

MARKET RESTRAINTS:

Factors like the raised official quality set by leaders of the market and robust regulatory framework imposition may hinder the overall growth of the market in the future years. Moreover, strict regulations and fetal bovine serum that is for cell culture production are to restrict the market growth. Additionally, ethical rules and statutes similar to using great expense in terms of support also act as a controlling administrator for the future extension of the market.

Additionally, market leaders' high standards of quality and the introduction of a robust regulatory framework are the main challenges for the market's growth over the next few years. The ethical rules and regulations that are proportionate to expensive infrastructure spending are also limiting factors for future market growth.

REPORT COVERAGE:

REPORT METRIC

DETAILS

Market Size Available

2021 to 2027

Base Year

2021

Forecast Period

2022 to 2027

Segments Covered

By Product, Application, End-User, and Region

Various Analyses Covered

Global, Regional & Country Level Analysis, Segment-Level Analysis, Drivers, Restraints, Opportunities, Challenges, PESTLE Analysis, Porter's Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities

Regions Covered

North America, Europe, Asia Pacific, Latin America, Middle East & Africa

 

This research report on the global cell culture market has been segmented and sub-segmented based on product, application, end-user, and region.

Cell Culture Market - By Product:

  • Equipment
    • Bioreactors
    • Cell Culture Vessels
    • Cell Culture Storage Equipment
    • Cell Culture Supporting Equipment
  • Consumables
    • Sera, Media & Reagents
    • Bioreactor Accessories

Based on the product, the equipment product-based segment is expected to occupy most of the market share during the forecast period. The growing scale of pharmaceutical industries is escalating the growth of the market.

The sera, media, and reagent segment has accounted for the largest share of the market. Sera and media is an integral part of the cell culture experiment; it gives a better result. Moreover, the segment has a large share because of repeated orders. 

Cell Culture Market - By Application:

  • Biopharmaceutical
    • Vaccine Production
    • Diagnostics
    • Recombinant Therapeutic Proteins
  • Cancer Research
  • Stem Cell Technologies
  • Drug Screening and Development
  • Tissue Engineering & Regenerative Medicine
  • Other Applications

Based on the application, the Biopharmaceutical application type leads with the most significant shares of the market. Increasing funds from private and public organizations are also elevating the demand of the cell culture market eventually.

Cell Culture Market - By End-User:

  • Pharmaceutical and Biotechnology Companies
  • Research Institutes

By end-user, the Pharmaceutical & biotechnology companies' end-user category is positioned top in leading the highest shares of the market. The rise in the number of healthcare centers and pharmaceutical companies to meet various drugs and vaccines is prompting the market's growth. Also, the acceptance of single-use technologies in the medical sector is bolstering the demand of the market.

Cell Culture Market - By Region:

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • The Middle East and Africa

Regionally, North America dominated the global cell culture market in 2019, accounting for 38% of the overall market share. North America has a large share of the market because of animal-component free media and an automated cell culture system, which reduces the time and increases production. -In addition, well-established healthcare demand for biopharmaceutical products, the research in pharmaceuticals, and the presence of the crucial player attribute in the growth of the cell culture market.

Europe and Asia-Pacific are in the 2nd and 3rd in holding the shares, respectively. Asia-Pacific to increase in the coming years, as is evident from the high CAGR value for the region. Another promising area for the Latin American market is to show high growth rates in the coming years.

The Asia Pacific region is to boost the market in the coming years. Due to the introduction and growth of mechanized cell culture methods and growing use of stem cell treatment in the sub-continent, cell culture finds the most application in Canadian and the United States life science labs.

KEY MARKET PARTICIPANTS:

A few of the companies playing a leading role in the global cell culture market profiled in this report are Thermo Fisher Scientific, GE Healthcare, Merck KGaA, Lonza AG, Sartorius AG, Eppendorf AG, Corning, Becton Dickinson and Company, Promocell GmbH, and Hi-Media Laboratories.

Leading vendors in the cell culture market focus on expanding their products and using strategies that help them collaborate to build a foothold across the market. Asia-Pacific and Latin America regions have the most potential to explore. Therefore, actors are developing cooperative programs to establish markets in the above areas. The key competitors in the cell culture market are General Electric healthcare, Sigma-Aldrich Co., Thermo Fisher Scientific, Becton, and Dickinson & Company.

GE Healthcare's portfolio includes both upstream and downstream processes, including high-volume manufacturing solutions and tools for process development, quality by design, analytical analysis, and flexible manufacturing. In Jan 2014, GE Healthcare acquired Thermo Fisher Scientific's cell culture media and serum, gene modulation technology, and magnetic beads for a total of $ 1.06 billion.

Thermo Fisher Scientific Company expanded its business in 2019 by investing $150 million in its Pharma Services business. The targets of this investment are providing a larger capacity for sterile liquids, commercializing the manufacturing process, and developing lyophilized products. The manufacturing sites in Italy and the U.S. will be adopting isolator technology and aseptic filling lines. The consumer base is likely to grow with this recent development in Thermo Fisher Scientific.

Merck Corporation opened a testing lab in 2018; conducting critical testing services and launching innovative therapies into the market are the primary objectives of this lab.

Fujifilm completed the acquisition of IS JAPAN co. And Irvine Scientific Company in 2018 to enhance regenerative medicine, reagent business, group synergies in the bio CDMO, and fuel the growth of cell culture media business for expanding its healthcare business.

Please wait. . . . Your request is being processed

Related Reports

Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2500

Didn’t find what you’re looking for?
TALK TO OUR ANALYST TEAM

Need something within your budget?
NO WORRIES! WE GOT YOU COVERED!

REACH OUT TO US

Call us on: +1 888 702 9696 (U.S Toll Free)

Write to us: sales@marketdataforecast.com

Click for Request Sample